In what could be the tip of the spear, Teva is attempting to become the first company to gain a court order to compel the sale of a brand drug for generic development. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
